|
|
|
|
|
|
|
|
|
|
Join Cell & Gene Live for an expert discussion on choosing the right manufacturing model for CGT pipelines. Industry leaders will examine centralized, decentralized, and hybrid approaches, sharing practical frameworks, operating models, and key tradeoffs affecting scalability, cost, timelines, and patient access. Featuring insights from Erin Harris, Omkar Kawalekar, and Zoe Zheng. Click here to learn more.
|
|
|
|
|
|
Webinar | MilliporeSigma
|
Explore the latest in lentiviral vector release testing, which covers biosafety, regulatory insights, and QC strategies to ensure patient safety and accelerate your path to clinic.
|
|
|
|
|
|
Webinar | Invetech
|
Discover how AI can optimize processes, improve efficiency, and enhance the understanding of cellular processes, ultimately leading to more effective and personalized patient treatments.
|
|
|
|
|
|
Webinar | Lonza
|
The streamlined AAV transient transfection platform de-risks your path to IND and reduces complexity and timeline for lengthy process and analytical development.
|
|
|
|
|
|
Video | Cell & Gene
|
In this first episode our in vivo-focused special series of Cell & Gene: The Podcast, Host Erin Harris speaks with Cassie Gorsuch, Ph.D., CSO at Precision Biosciences, about the rapid evolution of in vivo gene editing and the scientific, translational, and regulatory hurdles shaping the field.
|
|
|
|
|
|
Webinar | Precision for Medicine
|
Modernize your approach to drug development and see how integrated multi-omics and AI-driven analytics reveal profound biological insights, accelerating the path to clinical success.
|
|
|
|
|
|
Webinar | Siemens
|
AI insights are abundant in pharma, but action requires trust. Learn how governed, validated Industrial AI can move beyond advisory analytics to support compliant, auditable decisions.
|
|
|
|
|
|
|
|
|
|
Webinar: Building Scalable Non-Viral Gene-Edited Cell Therapy Processes
|
Discover practical strategies for scaling non-viral gene-edited cell therapies from early development to GMP-ready manufacturing. This webinar explores electroporation-based workflows for T, NK, and CD34+ cells, including CRISPR knock-out, knock-in, and transposon delivery. Learn how to balance editing efficiency with viability, expansion, and downstream process needs while optimizing scalable, closed-system manufacturing approaches for long-term success in cell therapy development. Click here to learn more.
|
|
|
| Connect With Cell & Gene: |
|
|
|
|
